Paul Seidler

Assistant Professor of Pharmacology and Pharmaceutical Sciences

Image of Paul Seidler
Is this your profile? Click to edit

Publications

  • Evidence for cPLA2 activation in Alzheimer’s disease synaptic pathology. Acta Neuropathol Commun. 2026 Feb 12; 14(1).. View in PubMed
  • Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy. Life Sci Alliance. 2026 Feb; 9(2).. View in PubMed
  • Evidence for cPLA2 activation in Alzheimer’s Disease Synaptic Pathology. bioRxiv. 2025 Apr 01.. View in PubMed
  • Selective Inhibition of hsp90 Paralogs: Uncovering the Role of Helix 1 in Grp94-Selective Ligand Binding. Proteins. 2025 Mar; 93(3):654-672.. View in PubMed
  • An ultra-broadband photonic-chip-based parametric amplifier. Nature. 2025 Mar; 639(8056):928-934.. View in PubMed
  • Monoaminergic neurotransmitters are bimodal effectors of tau aggregation. Sci Adv. 2025 Jan 31; 11(5):eadr8055.. View in PubMed
  • Improving the solubility of pseudo-hydrophobic chemicals through co-crystal formulation. PNAS Nexus. 2025 Jan; 4(1):pgaf007.. View in PubMed
  • Discovery of penicillic acid as a chemical probe against tau aggregation in Alzheimer’s disease. Chem Sci. 2024 Dec 11; 15(48):20467-20477.. View in PubMed
  • Tau seeds catalyze fibril-type structures from GFP tau biosensor cells. Structure. 2024 12 05; 32(12):2251-2258.e3.. View in PubMed
  • Selective inhibition of hsp90 paralogs: Uncovering the role of helix 1 in Grp94-selective ligand binding. bioRxiv. 2024 Aug 19.. View in PubMed
  • D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer’s disease. Sci Adv. 2024 05 03; 10(18):eadl2991.. View in PubMed
  • Oolonghomobisflavans from Camellia sinensis disaggregate tau fibrils across Alzheimer’s disease models. bioRxiv. 2024 Mar 01.. View in PubMed
  • A heterologous expression platform in Aspergillus nidulans for the elucidation of cryptic secondary metabolism biosynthetic gene clusters: discovery of the Aspergillus fumigatus sartorypyrone biosynthetic pathway. Chem Sci. 2023 Oct 18; 14(40):11022-11032.. View in PubMed
  • Structure-based design of nanobodies that inhibit seeding of Alzheimer’s patient-extracted tau fibrils. Proc Natl Acad Sci U S A. 2023 10 10; 120(41):e2300258120.. View in PubMed
  • A heterogeneously integrated lithium niobate-on-silicon nitride photonic platform. Nat Commun. 2023 Jun 13; 14(1):3499.. View in PubMed
  • Improving the solubility of pseudo-hydrophobic Alzheimer’s Disease medicinal chemicals through co-crystal formulation. bioRxiv. 2023 Apr 28.. View in PubMed
  • Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils. Nat Commun. 2023 04 25; 14(1):2379.. View in PubMed
  • Ultrafast tunable lasers using lithium niobate integrated photonics. Nature. 2023 03; 615(7952):411-417.. View in PubMed
  • Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proc Natl Acad Sci U S A. 2023 02 14; 120(7):e2217835120.. View in PubMed
  • Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro. Nat Commun. 2022 09 16; 13(1):5451.. View in PubMed
  • De novo designed protein inhibitors of amyloid aggregation and seeding. Proc Natl Acad Sci U S A. 2022 08 23; 119(34):e2206240119.. View in PubMed
  • Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies. Nat Struct Mol Biol. 2022 06; 29(6):529-536.. View in PubMed
  • Microwave-to-optical conversion with a gallium phosphide photonic crystal cavity. Nat Commun. 2022 Apr 19; 13(1):2065.. View in PubMed
  • Three-repeat and four-repeat tau isoforms form different oligomers. Protein Sci. 2022 03; 31(3):613-627.. View in PubMed
  • Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics. Vaccines (Basel). 2021 Oct 22; 9(11).. View in PubMed
  • Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimers Res Ther. 2021 Apr 19; 13(1):83.. View in PubMed
  • Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. bioRxiv. 2021 Mar 18.. View in PubMed
  • Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer’s disease. J Biol Chem. 2020 07 31; 295(31):10662-10676.. View in PubMed
  • Structure-based inhibitors halt prion-like seeding by Alzheimer’s disease-and tauopathy-derived brain tissue samples. J Biol Chem. 2019 11 01; 294(44):16451-16464.. View in PubMed
  • Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation. Alzheimers Res Ther. 2019 10 18; 11(1):86.. View in PubMed
  • Structure-based inhibitors of amyloid beta core suggest a common interface with tau. Elife. 2019 10 15; 8.. View in PubMed
  • Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors. J Biol Chem. 2018 02 23; 293(8):2888-2902.. View in PubMed
  • Structure-based inhibitors of tau aggregation. Nat Chem. 2018 02; 10(2):170-176.. View in PubMed
  • Atomic-resolution structures from fragmented protein crystals with the cryoEM method MicroED. Nat Methods. 2017 Feb 13; 14(4):399-402.. View in PubMed
  • Characterization of the Grp94/OS-9 chaperone-lectin complex. J Mol Biol. 2014 Oct 23; 426(21):3590-605.. View in PubMed
  • Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2. Nat Chem Biol. 2013 Nov; 9(11):677-84.. View in PubMed
  • Investigations of chemical modifications of amino-terminated organic films on silicon substrates and controlled protein immobilization. Langmuir. 2010 Feb 16; 26(4):2599-608.. View in PubMed
  • Formation, structure, and reactivity of amino-terminated organic films on silicon substrates. J Colloid Interface Sci. 2009 Jan 01; 329(1):114-9.. View in PubMed